亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Comparison of Two Different Techniques for Isolated Left Subclavian Artery Revascularization During Thoracic Endovascular Aortic Repair in Zone 2

医学 主动脉修补术 血运重建 左锁骨下动脉 心脏病学 锁骨下动脉 外科 内科学 冲程(发动机) 主动脉 主动脉弓 心肌梗塞 机械工程 工程类
作者
Gabriele Piffaretti,Giovanni Pratesi,Guido Gelpi,Mario Galli,Frank J. Criado,Michele Antonello,Federico Fontana,Filippo Piacentino,Edoardo Macchi,Matteo Tozzi,Patrizio Castelli,Matteo Barbante,Arnaldo Ippoliti,Claudia Romagnoni,Carlo Antona,Anita Paggi,Andrea Xodo,Franco Grego
出处
期刊:Journal of Endovascular Therapy [SAGE Publishing]
卷期号:25 (6): 740-749 被引量:33
标识
DOI:10.1177/1526602818802581
摘要

Purpose: To analyze the results of isolated left subclavian artery (LSA) revascularization during thoracic endovascular aortic repair (TEVAR) using carotid-subclavian bypass (CSbp) or chimney grafts (CGs). Methods: A retrospective multicenter, observational study identified 73 patients (mean age 68±13 years, range 22–87; 56 men) with acute or chronic thoracic aortic lesions who underwent TEVAR with isolated LSA revascularization using either CSbp (n=42) or CGs (n=31) from January 2010 and February 2017. Primary endpoints were TEVAR-related mortality, postoperative stroke, freedom from type Ia endoleak, and LSA patency. Results: Primary technical success was achieved in all cases. Early TEVAR-related mortality was 4.2% (CSbp 2% vs CG 6%, p=0.571). Two (3%) patients had major ischemic strokes (one in each group). Mean follow-up was 24±21 months (range 1–72; median 15). Estimated freedom from TEVAR-related mortality was 93%±3% (95% CI 84.3% to 97.0%) at 12 and 36 months, with no significant difference between CSbp and CG (p=0.258). Aortic reintervention did not differ between the groups (CSbp 5% vs CG 6%, p=0.356); nor did freedom from type Ia endoleak (CSbp 98% vs CG 87%, p=0.134). Gutter-related endoleaks occurred in 4 (13%) CG patients, but none of the patients experienced sac enlargement or the need for reintervention and none died. Primary patency of the LSA was 100% for the entire group during the observation period. Conclusion: In our experience, LSA revascularization proved most satisfactory and equally effective with both the CSbp and CG techniques, without discernible differences at midterm follow-up.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ys完成签到 ,获得积分10
1秒前
完美世界应助淡定的冬寒采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得10
17秒前
22秒前
虾鱼关注了科研通微信公众号
32秒前
Claudia发布了新的文献求助30
33秒前
量子星尘发布了新的文献求助10
39秒前
39秒前
41秒前
47秒前
虾鱼发布了新的文献求助10
48秒前
陶醉的安寒应助何88888888采纳,获得10
51秒前
小蘑菇应助Remon采纳,获得10
1分钟前
1分钟前
djdh完成签到 ,获得积分10
1分钟前
1分钟前
丘比特应助tdtk采纳,获得10
1分钟前
1分钟前
tdtk发布了新的文献求助10
1分钟前
1分钟前
我是老大应助Charles采纳,获得10
1分钟前
2分钟前
Dryang完成签到 ,获得积分10
2分钟前
2分钟前
gfasdjsjdsjd发布了新的文献求助10
2分钟前
Charles完成签到,获得积分10
2分钟前
2分钟前
英俊的铭应助Jasmine采纳,获得10
2分钟前
2分钟前
Charles发布了新的文献求助10
2分钟前
糖醋里脊发布了新的文献求助50
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
2分钟前
等待的剑身完成签到,获得积分10
2分钟前
smm发布了新的文献求助10
2分钟前
2分钟前
2分钟前
2分钟前
学术蟑螂发布了新的文献求助10
3分钟前
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Wearable Exoskeleton Systems, 2nd Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6058517
求助须知:如何正确求助?哪些是违规求助? 7891170
关于积分的说明 16296886
捐赠科研通 5203303
什么是DOI,文献DOI怎么找? 2783887
邀请新用户注册赠送积分活动 1766522
关于科研通互助平台的介绍 1647099